Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

2017 • 12,167 citations

BRAFMutations in Hairy-Cell Leukemia

2011 • 975 citations

TP53 Mutation and Survival in Chronic Lymphocytic Leukemia

2010 • 569 citations

Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-Chlorodeoxyadenosine

1990 • 521 citations

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)

2006 • 467 citations

Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's Lymphoma—A Randomized Phase II Trial of the Minnie Pearl Cancer Research Network

2005 • 338 citations

Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment

1998 • 318 citations

Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study

2010 • 311 citations

Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study

2009 • 274 citations

Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine

2003 • 273 citations

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

1995 • 268 citations

Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

2009 • 251 citations

Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire

1992 • 190 citations

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.

2000 • 170 citations

How I treat hairy cell leukemia

2009 • 162 citations

Pentostatin in the treatment of advanced hairy cell leukemia.

1989 • 155 citations

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy

2009 • 148 citations

Eradication of minimal residual disease in hairy cell leukemia

2006 • 126 citations

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior

2009 • 122 citations

PCR Analysis of Immunoglobulin Heavy Chain (IgH) and TcR-γ Chain Gene Rearrangements in the Diagnosis of Lymphoproliferative Disorders: Results of a Study of 525 Cases

2000 • 112 citations

Long remissions in hairy cell leukemia with purine analogs

2005 • 110 citations

Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine

1996 • 91 citations

Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine

2010 • 77 citations

Minimal Residual Disease Detection in Hairy Cell Leukemia

2003 • 60 citations

Minimal Residual Disease Detection in Hairy Cell Leukemia Comparison of Flow Cytometric Immunophenotyping With Clonal Analysis Using Consensus Primer Polymerase Chain Reaction for the Heavy Chain Gene

2003 • 55 citations

Hairy cell leukemia

2010 • 54 citations

The Role of Investigational Therapy in Management of Patients With Advanced Metastatic Malignancy

2008 • 36 citations

Evidence of canonical somatic hypermutation in hairy cell leukemia

2011 • 34 citations

Hairy Cell Leukemia: Treatment Successes in the Past 25 Years

2008 • 34 citations

Minimal Residual Disease in Hairy Cell Leukemia Patients Assessed by Clone-Specific Polymerase Chain Reaction

2006 • 33 citations

Soluble CD22 as a tumor marker for hairy cell leukemia

2008 • 28 citations

Chemo-immunotherapy for hairy cell leukemia

2011 • 17 citations

TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia

2010 • 11 citations